PANRE Longitudinal Assessment Internal Medicine Focus
Scope and Weight of IM in the Exam
Internal medicine for PA recertification is not merely a single category but the foundation upon which the majority of the PANRE-LA is built. The PANRE-LA adult medicine blueprint allocates a substantial percentage of questions to the diagnosis and chronic management of adult conditions. This reflects the reality of PA practice, where even those in specialties must often manage comorbid internal medicine conditions. The scoring system utilizes a scaled score model, where the difficulty of the specific questions answered correctly determines the final standing. In the longitudinal format, internal medicine topics often overlap with other categories like geriatrics or emergency medicine. For instance, a question about a patient with hypertension might also assess knowledge of renal protective strategies or cardiovascular risk stratification. Understanding the breadth of this scope is vital, as the exam prioritizes conditions with high prevalence and significant morbidity, ensuring that PAs are competent in managing the "bread and butter" of adult primary and acute care.
Approach to Studying Broad IM Content
Preparing for high-yield IM topics for PANRE-LA requires a strategy that favors long-term retention over rote memorization. Since the assessment allows for the use of references, the goal of studying is to build a robust mental framework that enables quick navigation of complex cases. Candidates should focus on the Level 1 and Level 2 depth of knowledge requirements defined by the NCCPA, which emphasize initial recognition and management. A successful study plan involves categorizing diseases by their pathophysiology—such as inflammatory versus infectious—and mastering the "first-line" interventions. For example, knowing the gold-standard diagnostic test for a suspected pulmonary embolism or the initial pharmacological choice for a newly diagnosed hypertensive patient is more valuable than memorizing obscure second-line alternatives. Utilizing a longitudinal approach to study, such as spaced repetition or case-based review, mirrors the exam's format and reinforces the clinician's ability to apply internal medicine principles across various organ systems and clinical settings.
Cardiology: Heart Failure, Ischemia, and Arrhythmias
Diagnosis and Staging of Heart Failure
A comprehensive PANRE-LA cardiology review must prioritize the distinction between Heart Failure with reduced Ejection Fraction (HFrEF) and Heart Failure with preserved Ejection Fraction (HFpEF). The diagnosis hinges on the clinical presentation—orthopnea, paroxysmal nocturnal dyspnea, and peripheral edema—supported by an elevated B-type Natriuretic Peptide (BNP) and echocardiography. For the PANRE-LA, PAs must be familiar with the ACC/AHA Stages of Heart Failure (A through D) and the NYHA Functional Classification (I through IV). Understanding these staging systems is critical because management transitions from risk factor modification in Stage A to advanced interventions in Stage D. Candidates should focus on the "four pillars" of HFrEF directed medical therapy: beta-blockers, ACE inhibitors/ARNs, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. Recognizing when to initiate these therapies and how to monitor for complications like hyperkalemia or hypotension is a recurring theme in the assessment.
Management of Stable CAD and ACS
Ischemic heart disease remains a leading cause of morbidity, making it a cornerstone of the cardiology section. The assessment frequently tests the ability to differentiate between stable angina and Acute Coronary Syndrome (ACS), which includes unstable angina, NSTEMI, and STEMI. PAs must master the interpretation of cardiac biomarkers, specifically high-sensitivity troponin, and understand the timing of these markers in the setting of myocardial infarction. Management strategies for stable Coronary Artery Disease (CAD) focus on risk reduction through statins, aspirin, and beta-blockers, whereas ACS management requires urgent stabilization and often invasive intervention. The exam may present scenarios involving the TIMI risk score or the HEART score to guide clinical decision-making regarding hospital admission and the urgency of catheterization. Understanding the contraindications to fibrinolytic therapy and the window for primary percutaneous coronary intervention (PCI) is essential for demonstrating competence in acute cardiac care.
Approach to Common Arrhythmias (AFib, SVT)
Arrhythmia management on the PANRE-LA centers on rhythm versus rate control and stroke prevention. Atrial Fibrillation (AFib) is the most frequently tested arrhythmia. Candidates must be proficient in using the CHA2DS2-VASc score to determine the necessity of anticoagulation. The distinction between valvular and non-valvular AFib is vital, as it dictates the choice between warfarin and Direct Oral Anticoagulants (DOACs). For Supraventricular Tachycardia (SVT), the assessment focuses on the acute treatment algorithm, starting with vagal maneuvers followed by intravenous adenosine. It is also important to recognize the EKG hallmarks of Wolff-Parkinson-White (WPW) syndrome—specifically the delta wave—and understand why certain AV-nodal blocking agents are contraindicated in these patients. Correctly identifying rhythm disturbances on a rhythm strip and matching them with the appropriate ACLS (Advanced Cardiovascular Life Support) guideline ensures success in this high-stakes subspecialty.
Pulmonology: Obstructive and Restrictive Diseases
COPD and Asthma Guidelines for Maintenance and Exacerbation
Pulmonology questions often revolve around the GOLD Criteria for COPD and the GINA Guidelines for asthma. For a PANRE-LA adult medicine blueprint review, PAs must understand the stepwise approach to treatment. In asthma, this involves the transition from "as-needed" low-dose ICS-formoterol to daily maintenance therapy. In COPD, the focus is on the "Group A, B, or E" classification based on symptom burden and exacerbation history. Clinicians must be able to interpret Spirometry results, specifically the FEV1/FVC ratio; a post-bronchodilator ratio of less than 0.70 confirms airflow limitation in COPD. Management of acute exacerbations is another high-yield area, requiring knowledge of systemic corticosteroids, short-acting bronchodilators, and the appropriate use of antibiotics when increased sputum purulence or volume is present. Understanding the role of supplemental oxygen and the risks of hypercapnia in chronic CO2 retainers is also crucial for safe practice.
Interstitial Lung Disease and Pulmonary Fibrosis Basics
Restrictive lung diseases present a different diagnostic challenge, characterized by reduced total lung capacity and impaired gas exchange. The PANRE-LA focuses on the clinical recognition of Interstitial Lung Disease (ILD), often through the presentation of progressive exertional dyspnea and "velcro-like" inspiratory crackles. Idiopathic Pulmonary Fibrosis (IPF) is the most common form, and its diagnosis often requires high-resolution computed tomography (HRCT) showing a pattern of usual interstitial pneumonia (UIP). PAs should be prepared to identify occupational causes of ILD, such as asbestosis or silicosis, by taking a detailed social and work history. The management of these conditions is largely supportive, but recognizing the role of antifibrotic medications and the importance of early referral for lung transplantation evaluation is a key competency. Differentiation between ILD and other causes of restrictive patterns, such as obesity hypoventilation syndrome or neuromuscular weakness, is frequently assessed.
Diagnosis and Management of Pleural Effusions
Evaluating pleural effusions requires an understanding of Light’s Criteria to differentiate between transudative and exudative fluids. This is a classic internal medicine topic where the protein and LDH levels of the pleural fluid are compared to serum values. Transudates are typically caused by systemic factors like heart failure or cirrhosis, while exudates result from local inflammatory processes like pneumonia (parapneumonic effusion) or malignancy. The PANRE-LA may test the clinician's ability to interpret these lab values and determine the next step in management, which may include thoracentesis for diagnostic or therapeutic purposes. Recognizing "red flag" pleural fluid findings, such as a low pH or low glucose level, which suggest a complicated effusion or empyema requiring chest tube drainage, is critical. This section reinforces the need for a systematic approach to fluid analysis and its integration into the broader clinical picture of the patient.
Type 2 Diabetes Pharmacotherapy and Complication Monitoring
A thorough PANRE-LA endocrinology study must center on the evolving landscape of Type 2 Diabetes management. Beyond Metformin, PAs must understand the specific indications for SGLT2 inhibitors and GLP-1 receptor agonists, particularly their benefits in patients with established cardiovascular disease or chronic kidney disease. The assessment tests the ability to manage Hemoglobin A1c targets, which are often individualized based on age and comorbidities. Monitoring for microvascular complications is equally important; this includes annual screening for diabetic retinopathy, nephropathy (via urine albumin-to-creatinine ratio), and peripheral neuropathy. Recognition and acute management of hyperglycemic crises, such as Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS), are essential. PAs must be able to distinguish between these two based on pH, bicarbonate levels, and serum osmolarity, and initiate appropriate fluid resuscitation and insulin protocols.
Hypothyroidism, Hyperthyroidism, and Thyroid Nodule Workup
Thyroid disorders are common in primary care and are frequently featured in the PANRE-LA. The primary screening tool is the Thyroid Stimulating Hormone (TSH) level. PAs must be adept at interpreting the relationship between TSH and free T4 to diagnose primary versus secondary hypothyroidism or hyperthyroidism. Management of Graves' disease, including the use of methimazole or radioactive iodine, and the treatment of Hashimoto’s thyroiditis with levothyroxine, are core topics. When a thyroid nodule is discovered, the assessment focuses on the diagnostic algorithm: starting with TSH and ultrasound, followed by a Fine Needle Aspiration (FNA) if the nodule meets specific size or sonographic criteria (such as the TI-RADS classification). Understanding when to perform a thyroid uptake scan—specifically when TSH is suppressed—is a nuanced point that reflects the advanced preparation required for the longitudinal assessment.
Osteoporosis Screening, Prevention, and Treatment
Metabolic bone disease, specifically osteoporosis, is a critical area of adult medicine due to the high risk of fragility fractures in the aging population. The PANRE-LA focuses on the interpretation of the DEXA scan and the significance of the T-score (where a score of -2.5 or lower defines osteoporosis). Candidates must also be familiar with the FRAX tool, which calculates the 10-year probability of a major osteoporotic fracture to guide treatment decisions in patients with osteopenia. Prevention strategies, including adequate calcium and Vitamin D intake and weight-bearing exercise, are fundamental. Pharmacological management usually begins with bisphosphonates; however, PAs must know the contraindications, such as esophageal disorders or severe renal impairment (CrCl < 35 mL/min), and the rare but serious side effects like osteonecrosis of the jaw. This section emphasizes the PA's role in proactive screening and long-term management of bone health to prevent catastrophic falls and fractures.
Gastroenterology and Hepatology Essentials
GERD, PUD, and H. pylori Management
Gastrointestinal disorders often present with overlapping symptoms of dyspepsia and epigastric pain. The PANRE-LA requires PAs to distinguish between Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease (PUD). A key competency is identifying "alarm symptoms" such as weight loss, dysphagia, or anemia, which necessitate urgent referral for an Upper Endoscopy (EGD). The management of Helicobacter pylori is a high-yield topic, focusing on the various testing modalities (urea breath test, stool antigen, or biopsy) and the shift toward quadruple therapy as the first-line treatment in areas of high clarithromycin resistance. Understanding the role of Proton Pump Inhibitors (PPIs) in healing ulcers and managing reflux, as well as the long-term risks associated with their use (such as C. difficile infection or bone loss), is essential for comprehensive patient care and exam performance.
Inflammatory Bowel Disease: Differentiating UC and Crohn's
Distinguishing between Ulcerative Colitis (UC) and Crohn's Disease is a classic internal medicine challenge tested on the PANRE-LA. UC is typically characterized by bloody diarrhea, tenesmus, and continuous inflammation limited to the colon and rectum, almost always involving the mucosa only. In contrast, Crohn's Disease can affect any part of the GI tract, is often "skip" in distribution, and involves transmural inflammation that can lead to fistulas or strictures. PAs should be familiar with the extra-intestinal manifestations of IBD, such as uveitis, erythema nodosum, and primary sclerosing cholangitis. Management involves a "step-up" or "top-down" approach using 5-ASAs, corticosteroids for flares, and immunomodulators or biologic agents for maintenance. The assessment also focuses on the increased risk of colorectal cancer in these patients, necessitating more frequent colonoscopic surveillance based on the duration and extent of the disease.
Cirrhosis Complications and Hepatitis Screening
Hepatology on the PANRE-LA focuses on the management of chronic liver disease and the screening for viral hepatitis. Clinicians must recognize the signs of portal hypertension, including ascites, esophageal varices, and hepatic encephalopathy. Management of ascites involves sodium restriction and the use of diuretics (typically a ratio of Spironolactone to Furosemide), while encephalopathy is managed with lactulose or rifaximin. Screening for Hepatitis C is now recommended for all adults at least once in their lifetime, and PAs must be able to interpret the Hepatitis B serology panel (HBsAg, anti-HBs, anti-HBc) to differentiate between acute infection, chronic infection, and immunity. Furthermore, the assessment may cover the screening for hepatocellular carcinoma (HCC) in cirrhotic patients using ultrasound and alpha-fetoprotein (AFP) every six months, highlighting the importance of longitudinal monitoring in chronic liver disease.
Nephrology, Infectious Disease, and Rheumatology
Acute Kidney Injury and Chronic Kidney Disease Management
Nephrology questions on the PANRE-LA prioritize the recognition of Acute Kidney Injury (AKI) and the staging of Chronic Kidney Disease (CKD). AKI is categorized into prerenal, intrinsic, and postrenal causes. PAs must be able to calculate and interpret the Fractional Excretion of Sodium (FeNa); a value less than 1% typically suggests a prerenal etiology, while a value greater than 2% points toward Acute Tubular Necrosis (ATN). In the realm of CKD, management focuses on slowing progression through blood pressure control (often with ACE inhibitors or ARBs for their antiproteinuric effects) and managing complications like secondary hyperparathyroidism, anemia of chronic disease, and electrolyte disturbances. Understanding the indications for urgent dialysis—often remembered by the mnemonic "AEIOU" (Acidosis, Electrolytes, Ingestion, Overload, Uremia)—is a critical safety-related competency tested in the assessment.
Antibiotic Stewardship for Common Infections
Infectious disease is a pervasive theme in internal medicine for PA recertification. The PANRE-LA emphasizes appropriate antibiotic selection for common community-acquired infections. For example, treating Community-Acquired Pneumonia (CAP) requires knowledge of the CURB-65 score to determine the setting of care and the choice between macrolides, tetracyclines, or beta-lactam/macrolide combinations. PAs must also be proficient in managing Uncomplicated Cystitis versus Pyelonephritis, recognizing the rising resistance patterns of E. coli. Stewardship principles involve choosing the narrowest spectrum agent possible and adhering to recommended durations of therapy to prevent the development of multi-drug resistant organisms. Other high-yield topics include the recognition of cellulitis (and differentiating it from stasis dermatitis), the initial management of sepsis with fluid resuscitation and broad-spectrum antibiotics, and the current adult immunization schedules.
Diagnosing Rheumatoid Arthritis, Lupus, and Gout
Rheumatology topics on the PANRE-LA focus on the clinical differentiation of various arthritides. Rheumatoid Arthritis (RA) presents as a symmetric, small-joint polyarthritis with significant morning stiffness, often associated with positive Rheumatoid Factor (RF) or anti-CCP antibodies. Systemic Lupus Erythematosus (SLE) is a multisystem disease requiring a combination of clinical and serological criteria (such as ANA, anti-dsDNA, and anti-Smith antibodies) for diagnosis. Gout, the most common inflammatory arthritis in men, is diagnosed by the presence of negatively birefringent needle-shaped crystals on synovial fluid analysis. Management of gout involves acute treatment with NSAIDs, colchicine, or steroids, followed by long-term urate-lowering therapy like allopurinol for those with frequent flares or tophi. PAs must also be aware of the screening and management of osteoporosis in patients on chronic corticosteroid therapy for rheumatic diseases.
Neurology and Hematology/Oncology for Primary Care
Evaluating Headache, Stroke, and Seizure
Neurology on the PANRE-LA covers both acute and chronic conditions. Headache evaluation focuses on distinguishing primary headaches (migraine, tension, cluster) from secondary causes. PAs must recognize "red flags" such as sudden onset ("thunderclap"), fever, or focal neurological deficits, which necessitate imaging to rule out subarachnoid hemorrhage or mass lesions. Stroke management is a time-sensitive topic; recognizing the symptoms of a TIA or acute ischemic stroke and understanding the window for Tissue Plasminogen Activator (tPA) administration (usually within 3 to 4.5 hours of symptom onset) is vital. For seizure disorders, the assessment may cover the differentiation between generalized and focal seizures and the initial pharmacological management with antiepileptic drugs (AEDs). PAs should also be familiar with the workup of syncope, focusing on cardiac versus neurological etiologies, often utilizing the EKG as the first-line diagnostic tool.
Anemia Workup and Anticoagulation Management
Hematology questions frequently center on the systematic approach to anemia, classified by the Mean Corpuscular Volume (MCV). Microcytic anemia (low MCV) requires a workup for iron deficiency (the most common cause globally), thalassemias, or lead poisoning. Macrocytic anemia (high MCV) necessitates checking Vitamin B12 and folate levels, with attention to the neurological symptoms associated with B12 deficiency. Anticoagulation management is another critical area, particularly the transition from heparin to warfarin (requiring "bridging") or the use of DOACs for AFib and Venous Thromboembolism (VTE). PAs must know how to manage supratherapeutic International Normalized Ratio (INR) levels and when to administer Vitamin K or prothrombin complex concentrate (PCC) in the event of bleeding. This requires a precise understanding of the coagulation cascade and the mechanism of action of various antithrombotic agents.
Cancer Screening Guidelines and Palliative Care Principles
Oncology for the PANRE-LA is focused on the role of the primary care PA in screening and early detection. This includes adhering to USPSTF Guidelines for breast cancer (mammography), colorectal cancer (colonoscopy or stool-based tests), lung cancer (low-dose CT for smokers), and cervical cancer (Pap and HPV testing). Recognizing the clinical presentation of common malignancies—such as the "painless hematuria" of bladder cancer or the "constitutional symptoms" of lymphoma—is essential. Additionally, the assessment covers the principles of palliative care, emphasizing symptom management (pain, dyspnea, nausea) and the importance of advance care planning. PAs must be able to facilitate discussions regarding "Goals of Care" and understand the difference between palliative care and hospice. This holistic approach ensures that candidates are prepared to support patients through the entire continuum of cancer care, from screening to end-of-life support.